Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Meeting Overview topic
No spam. Unsubscribe anytime.
Maine Board of Pharmacy approves multiple licenses, schedules hearings and adopts staff-delegation policy
Summary
At its June 4, 2026 virtual meeting, the Maine Board of Pharmacy approved multiple individual and company licenses, scheduled adjudicatory hearings and consent agreements that included civil penalties and continuing-education requirements, adopted a Limited Staff Delegation policy, and adjourned at 12:53 p.m.
The Maine Board of Pharmacy convened virtually on June 4, 2026, with Edward Kane, Esq., Public Member, presiding. The board approved multiple individual and company licenses, issued reminders to licensees about the statutory 10-day reporting requirement (10 M.R.S. 8003‑G(2)), scheduled adjudicatory hearings with proposed consent agreements in several complaint cases, adopted a Draft Limited Staff Delegation Policy and adjourned at 12:53 p.m.
Board actions included approval of individual initial licenses such as Alice Edgerly (PT600020752) and Adam McKinley (PT60020670) and approvals for companies including Amerita, Inc. (MO400003879) and Professional Compounding Centers of America (WH70003663 and WH70003664). The board also scheduled hearings and offered consent agreements that in some cases included civil penalties—commonly $2,500 in the matters described in the minutes—and continuing-education conditions. Director Penny Vaillancourt told the board staff will work on the Central Fill rule in the next legislative session; the board adopted the Limited Staff Delegation policy as presented.
The board’s procedural items included tabling the minutes of May 7, 2026, and taking no action on submitted correspondence from PharmaLicense, New England Life Care, and one withdrawn examination-retake request. No members of the public spoke during the public-comment period.
